CLINICAL_TRIALS
trial_result
· 2011-05-24
Clinical Trial Update: E3 Breast Cancer Taxotere Combination [Phase 2]
Summary
A Phase 2 trial evaluating a Taxotere (docetaxel) combination for advanced breast cancer, with results posted in May 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-24